Your browser doesn't support javascript.
loading
Cost-effectiveness of treprostinil versus epoprostenol in patients with pulmonary arterial hypertension: a Canadian analysis.
Einarson, T R; Granton, John T; Vicente, Colin; Walker, John; Engel, Greg; Iskedjian, Michael.
Affiliation
  • Einarson TR; Faculty of Pharmacy, University of Toronto, Toronto, Canada.
Can Respir J ; 12(8): 419-25, 2005.
Article in En | MEDLINE | ID: mdl-16331313
Subject(s)
Search on Google
Add to My VHL
Print
XML
PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Epoprostenol / Hypertension, Pulmonary / Antihypertensive Agents Type of study: Health_economic_evaluation Limits: Female / Humans / Male Country/Region as subject: America do norte Language: En Journal: Can Respir J Year: 2005 Document type: Article Affiliation country: Canada Country of publication: Egypt
Search on Google
Add to My VHL
Print
XML
PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Epoprostenol / Hypertension, Pulmonary / Antihypertensive Agents Type of study: Health_economic_evaluation Limits: Female / Humans / Male Country/Region as subject: America do norte Language: En Journal: Can Respir J Year: 2005 Document type: Article Affiliation country: Canada Country of publication: Egypt